Results

Total Results: 1,767 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
    October 01, 2016 - among patient-relevant outcomes are common; for example, effective treatments may be associated with adverse … concern”) and the 2003 ISPOR principles of good practice38 (“analytic methodology that accounts for events
  2. effectivehealthcare-admin.ahrq.gov/products/aggression/research-protocol
    January 01, 2020 - in meta-analyses; characteristics of included studies, populations, and interventions; results; and adverseevents, if reported. … Individual Studies To minimize risk of bias in observational and noncontrolled studies addressing adverse
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
    September 23, 2014 - rates of harms of imaging techniques…” Most do not use the term “rates of harms” and instead consider “adverseevents.” … Given current sedation use, patients are very seldom aware of any EUS intra-procedural events and rarely
  4. effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
    November 01, 2019 - Effect of nighttime surgery on mortality and adverse events: a systematic review and meta-analysis. … procedures under anesthesia performed at nighttime on outcomes.83 Outcomes include mortality, incidence of adverseevents (both intraoperative and postoperative); hospital length of stay; unplanned admission to the
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - As chemotherapy-related adverse effects (i.e., toxicity) may also be a more specific indicator of overly … Chemotherapy toxicity was calculated for events that occurred between the receipt of the first chemotherapy … Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women … Chemotherapy toxicity was calculated for events that occurred between the receipt of the first chemotherapy
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
    March 01, 2012 - studies reported that such infants were subsequently hospitalized and treated with antibiotics without adverseevents. … Although reassuring, the absence of adverse events in these studies may be partially explained by underreporting
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
    April 01, 2012 - impairment, patient- reported outcomes, intraocular pressure, visual field loss, optic nerve damage, and adverse … case series of fewer than 100 participants, as studies smaller than this are expected to identify events … KQ6 We recorded the proportion of participants experiencing the following adverse events (adapted from
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
    January 01, 2014 - uninterpretable because there were no standard metrics for assessing pain, quality of life, or adverse … enrolled in studies of chronic venous ulcer treatment should be monitored actively to detect any adverseevents that could be related to their treatment. … All such events should be described in the articles that report the results of such studies. … Knowledge of the reasons for losses to followup (e.g., adverse events) are useful for clinicians’ and
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
    January 01, 2010 - assessment tool. 26 Additionally, we plan to use selected items from the McHarm Tool to assess adverseevents. 27 We will supplement these tools with additional quality-assessment questions based on
  10. effectivehealthcare-admin.ahrq.gov/products/insulin-blood-sugar-2010/research-protocol
    December 01, 2019 - quality assessment tool. 26 Additionally, we plan to use selected items from the McHarm Tool to assess adverseevents. 27 We will supplement these tools with additional quality-assessment questions based on recommendations
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
    February 10, 2016 - potential  to  create  enough  space  in  the  oropharynx  that   the  child  no  longer  has  obstructive  events … the  literature,  and  the  larger  sample  size  should  allow  us  to   capture  data  on  rarer  adverse …  events.      
  12. effectivehealthcare-admin.ahrq.gov/products/tonsillectomy/research-protocol
    March 01, 2020 - has the potential to create enough space in the oropharynx that the child no longer has obstructive events … tonsillectomy in the literature, and the larger sample size should allow us to capture data on rarer adverseevents.
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
    August 01, 2013 - Post-market events (within 2 years of FDA approval) occurred that could change the premarket projections … surgical strategies, new methods of drug delivery, or possible reductions in the complexity, cost, or adverse … invasiveness, degree of physical and mental capacity required for use, anticipated side effects, risks, adverseevents.
  14. effectivehealthcare-admin.ahrq.gov/products/nonpharma-treatment-pain/research-protocol
    December 01, 2019 - on outcomes from validated measures Function/disability/pain interference Pain Harms and adverse … from validated measures for Function/disability/pain interference § Pain § Harms and Adverse
  15. effectivehealthcare-admin.ahrq.gov/products/effect-protein-intake/protocol
    December 01, 2023 - states), intervention and control characteristics, comparison, outcomes cited, results of outcomes and adverse … Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
    December 14, 2017 - Section Comment Response TEP Reviewer #2 Executive Summary Better to say 'provided information on adverse … effects' We use the term "harms" to imply the range of adverse events captured. … We have searched for the word rate and corrected instances in which it does to refer to events per unit
  17. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
    October 05, 2015 - in meta-analyses; characteristics of included studies, populations, and interventions; results; and adverseevents, if reported. … Individual Studies To minimize risk of bias in observational and noncontrolled studies addressing adverse
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - and clinicians, experts thought; however, other barriers to acceptance may include the frequency of adverseevents and the need for faithful adherence to the treatment regimen for maximum efficacy. … No adverse events were reported from fecal transplantation. 104 Fecal bacteriotherapy is being implemented … Adverse events were similar in both trials and not different among the treatments. 117 In another … compared with 35.5% of patients receiving vancomycin (p =0.045), a 45% reduction in repeat recurrent events
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-review-implicit-bias.pdf
    January 01, 2024 - report identified reported linkages between implicit bias and patient safety such as underreporting events … The MHS III report noted that more can be done to explore the link between adverse safety events and … PSP was defined to focus on implicit bias training to recognize differential risks of patient safety events … healthcare, healthcare utilization, diagnostic error, mortality, quality (e.g., patient satisfaction), adverse … Malpractice, medicolegal risk complaints • Primary outcomes: HCW outcomes, for example o HCW adverse
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - once or twice daily, at a dose of 24 IU, for periods between 1 and 8 weeks.21-29 A large review of adverse-event

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: